These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 3756910

  • 1. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines.
    Senger DR, Perruzzi CA, Feder J, Dvorak HF.
    Cancer Res; 1986 Nov; 46(11):5629-32. PubMed ID: 3756910
    [Abstract] [Full Text] [Related]

  • 2. Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor.
    Senger DR, Connolly DT, Van de Water L, Feder J, Dvorak HF.
    Cancer Res; 1990 Mar 15; 50(6):1774-8. PubMed ID: 2155059
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions.
    Yeo KT, Wang HH, Nagy JA, Sioussat TM, Ledbetter SR, Hoogewerf AJ, Zhou Y, Masse EM, Senger DR, Dvorak HF.
    Cancer Res; 1993 Jun 15; 53(12):2912-8. PubMed ID: 8504432
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of vascular permeability factor (vascular endothelial growth factor) with antipeptide antibodies.
    Sioussat TM, Dvorak HF, Brock TA, Senger DR.
    Arch Biochem Biophys; 1993 Feb 15; 301(1):15-20. PubMed ID: 8442657
    [Abstract] [Full Text] [Related]

  • 8. Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor.
    Pötgens AJ, van Altena MC, Lubsen NH, Ruiter DJ, de Waal RM.
    Am J Pathol; 1996 Apr 15; 148(4):1203-17. PubMed ID: 8644861
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xenografted to nude mice.
    Pötgens AJ, Lubsen NH, van Altena MC, Schoenmakers JG, Ruiter DJ, de Waal RM.
    Am J Pathol; 1995 Jan 15; 146(1):197-209. PubMed ID: 7531947
    [Abstract] [Full Text] [Related]

  • 14. Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor.
    Heiss JD, Papavassiliou E, Merrill MJ, Nieman L, Knightly JJ, Walbridge S, Edwards NA, Oldfield EH.
    J Clin Invest; 1996 Sep 15; 98(6):1400-8. PubMed ID: 8823305
    [Abstract] [Full Text] [Related]

  • 15. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S, Herbst RS, Shinohara H, Knighton B, Bucana CD, Killion JJ, Wood J, Fidler IJ.
    Clin Cancer Res; 2000 Mar 15; 6(3):957-65. PubMed ID: 10741721
    [Abstract] [Full Text] [Related]

  • 16. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis.
    Rak J, Mitsuhashi Y, Bayko L, Filmus J, Shirasawa S, Sasazuki T, Kerbel RS.
    Cancer Res; 1995 Oct 15; 55(20):4575-80. PubMed ID: 7553632
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
    Abu-Jawdeh GM, Faix JD, Niloff J, Tognazzi K, Manseau E, Dvorak HF, Brown LF.
    Lab Invest; 1996 Jun 15; 74(6):1105-15. PubMed ID: 8667614
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions.
    Brown LF, Olbricht SM, Berse B, Jackman RW, Matsueda G, Tognazzi KA, Manseau EJ, Dvorak HF, Van de Water L.
    J Immunol; 1995 Mar 15; 154(6):2801-7. PubMed ID: 7876550
    [Abstract] [Full Text] [Related]

  • 20. Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal microvascular endothelial cells.
    Watanabe Y, Lee SW, Detmar M, Ajioka I, Dvorak HF.
    Oncogene; 1997 May 01; 14(17):2025-32. PubMed ID: 9160882
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.